The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ROCHOP study: A phase III randomized study of CHOP compared to romidepsin-CHOP in untreated peripheral T-cell lymphoma.
Richard Delarue
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Pier Luigi Zinzani
No relevant relationships to disclose
Mark S. Hertzberg
No relevant relationships to disclose
Won Seog Kim
No relevant relationships to disclose
Dolores Caballero
No relevant relationships to disclose
Antonio Pezzutto
No relevant relationships to disclose
Marc Andre
No relevant relationships to disclose
Maria Gomes Da Silva
No relevant relationships to disclose
Philippe Gaulard
No relevant relationships to disclose
Bertrand Coiffier
Consultant or Advisory Role - Celgene
Honoraria - Celgene